Romosozumab in postmenopausal women with smoldering multiple myeloma: a prospective 12-mo study.

JBMR Plus · 2025 · PMC12452266 · PMID 40989498

Europe PMC DOI

hedged sentence

0.0600

closest p · 1.2× alpha

0.0600

boldest claim

The sentences

a trend toward significancep = .060so close (0.05 < p ≤ 0.1)

C-terminal telopeptide of type I collagen decreased progressively, showing a trend toward significance (−53.6%, p = .060).

also in 1,319 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.